Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Divergent trajectories of antiviral memory after SARS-CoV-2 infection

Tomic A. et al, (2022), Nature Communications, 13

Characterisation of SARS-CoV-2 genomic variation in response to molnupiravir treatment in the AGILE Phase IIa clinical trial.

Donovan-Banfield I. et al, (2022), Nat Commun, 13

An introduction to the Marburg virus vaccine consortium, MARVAC.

Cross RW. et al, (2022), PLoS pathogens, 18

Avatar Mice Underscore the Role of the T Cell-Dendritic Cell Crosstalk in Ebola Virus Disease and Reveal Mechanisms of Protection in Survivors.

Rottstegge M. et al, (2022), Journal of virology

Hypoxia inducible factors regulate infectious SARS-CoV-2, epithelial damage and respiratory symptoms in a hamster COVID-19 model.

Wing PAC. et al, (2022), PLoS pathogens, 18

A prototype lateral flow assay for detection of orthopoxviruses.

Ulaeto DO. et al, (2022), The Lancet. Infectious diseases, 22, 1279 - 1280

Convalescent plasma donors show enhanced cross-reactive neutralizing antibody response to antigenic variants of SARS-CoV-2 following immunization.

Harvala H. et al, (2022), Transfusion, 62, 1347 - 1354

Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses.

McNaughton AL. et al, (2022), JCI insight

Analysis of SARS-CoV-2 in Nasopharyngeal Samples from Patients with COVID-19 Illustrates Population Variation and Diverse Phenotypes, Placing the Growth Properties of Variants of Concern in Context with Other Lineages.

Prince T. et al, (2022), mSphere

SARS-CoV-2-Specific T Cell Responses Are Not Associated with Protection against Reinfection in Hemodialysis Patients

Shankar S. et al, (2022), Journal of the American Society of Nephrology, 33, 883 - 887

Synthetic Heparan Sulfate Mimetic Pixatimod (PG545) Potently Inhibits SARS-CoV-2 by Disrupting the Spike-ACE2 Interaction.

Guimond SE. et al, (2022), ACS central science, 8, 527 - 545

Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV

Ogbe A. et al, (2022), JCI Insight, 7

Ribavarin for treating Lassa fever: A systematic review of pre-clinical studies and implications for human dosing.

Salam AP. et al, (2022), PLoS Negl Trop Dis, 16

Multisystem screening reveals SARS-CoV-2 in neurons of the myenteric plexus and in megakaryocytes.

Gray-Rodriguez S. et al, (2022), The Journal of pathology

Analysis of SARS-CoV-2 known and novel subgenomic mRNAs in cell culture, animal model, and clinical samples using LeTRS, a bioinformatic tool to identify unique sequence identifiers

Dong X. et al, (2022), GigaScience, 11

Complement-Mediated Neutralisation Identified in Ebola Virus Disease Survivor Plasma: Implications for Protection and Pathogenesis.

Mellors J. et al, (2022), Frontiers in immunology, 13

Development of anti-Crimean-Congo hemorrhagic fever virus Gc and NP-specific ELISA for detection of antibodies in domestic animal sera.

Belij-Rammerstorfer S. et al, (2022), Frontiers in veterinary science, 9

mRNA vaccination drives differential mucosal neutralizing antibody profiles in naïve and SARS-CoV-2 previously-infected individuals.

Longet S. et al, (2022), Frontiers in immunology, 13

The characterization of multiple novel paramyxoviruses highlights the diverse nature of the subfamily Orthoparamyxovirinae.

Vanmechelen B. et al, (2022), Virus evolution, 8

Vaccine-Associated Enhanced Disease and Pathogenic Human Coronaviruses.

Gartlan C. et al, (2022), Frontiers in immunology, 13

Load More

Include forthcoming?